Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24, SINUS-52 phase 3 studies

被引：0
|
作者：
Desrosiers, M. [1 ]
Bachert, C. [2 ,3 ]
Hellings, P. W. [4 ]
Hopkins, C. [5 ]
Olze, H. [6 ]
Han, J. K. [7 ]
Lee, S. E. [8 ]
Zhang, M. [9 ]
Lu, X. [9 ]
Amin, N. [10 ]
Patel, N. [9 ]
Graham, N. M. H. [10 ]
Ruddy, M. [10 ]
Staudinger, H. [9 ]
Mannent, L. P. [11 ]
机构：
[1] CRCHUM, Montreal, PQ, Canada
[2] Univ Ghent, Upper Airways Res Lab, Ghent, Belgium
[3] Karolinska Inst, Stockholm, Sweden
[4] Univ Hosp Leuven, Leuven, Belgium
[5] Guys & St Thomas Hosp, London, England
[6] Charite Univ Med Berlin, Dept Otorhinolaryngol Head & Neck Surg, Berlin, Germany
[7] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[8] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[9] Sanofi, Bridgewater, MA USA
[10] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[11] Sanofi, Chilly Mazarin, France
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
PD0613
引用
收藏
页码：330 / 331
页数：2
相关论文
共 42 条
  • [1] Dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyposis: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies
    Bachert, C.
    Fokkens, W. J.
    Jankowski, R.
    Cervin, A. U.
    Laidlaw, T. M.
    Lee, S. E.
    Zhang, M.
    Lu, X.
    Amin, N.
    Patel, N.
    Graham, N. M. H.
    Ruddy, M.
    Staudinger, H.
    Mannent, L. P.
    ALLERGY, 2019, 74 : 55 - 56
  • [2] Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps: Pooled results from the SINUS-24 and SINUS-52 phase 3 studies
    Mullol, J.
    Bachert, C.
    Desrosiers, M.
    Han, J. K.
    Jankowski, R.
    Daizadeh, N.
    Amin, N.
    Mannent, L. P.
    Khan, A. H.
    Kamat, S.
    ALLERGY, 2020, 75 : 226 - 226
  • [3] Dupilumab Treatment Improves Sense of Smell in Patients With Chronic Rhinosinusitis With Nasal Polyps - Pooled Results From the SINUS-24 and SINUS-52 Phase 3 Trials
    Mullol, Joaquim
    Han, Joseph
    Bosso, John
    Mannent, Leda
    Amin, Nikhil
    Cho, Seong
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB169 - AB169
  • [4] Rapid and Sustained Effects of Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps: Analysis of the SINUS-24 and SINUS-52 Phase 3 Trails
    Hellings, P. W.
    Peters, A.
    Chaker, A. M.
    Heffler, E.
    Zhang, H.
    Daizadeh, N.
    Nash, S.
    Khan, A. H.
    Siddiqui, S.
    Jacob-Nara, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [5] Baseline Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma from the Pooled Populations of the SINUS-24 and SINUS-52 Dupilumab Phase 3 Trials
    Desrosiers, M.
    Mullol, J.
    Forwith, K.
    Gevaert, P.
    Maspero, J. F.
    Zhang, M.
    Mao, X.
    Amin, N.
    Mannent, L. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [6] Dupilumab Improves Upper and Lower Airway Outcome Measures in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma: Pooled Results from the SINUS-24 and SINUS-52 Phase 3 Studies
    Laidlaw, T.
    Cho, S.
    Maspero, J. F.
    Canonica, G. W.
    Sher, L.
    Bachert, C.
    Han, J. K.
    Mao, X.
    Zhang, M.
    Patel, N.
    Graham, N. M. H.
    Staudinger, H.
    Mannent, L. P.
    Amin, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [7] Dupilumab Provides Early and Durable Improvement of Symptoms in Patients with Chronic Rhinosinusitis with Nasal Polyps: Results from the SINUS-24 and SINUS-52 Phase 3 Trials
    Gevaert, P.
    Lee, S. E.
    Settipane, R.
    Wagenmann, M.
    Msihid, J.
    Siddiqui, S.
    Nash, S.
    Jacob-Nara, J. A.
    Khan, A. H.
    Kamat, S.
    Chuang, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [8] Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52
    Bachert, Claus
    Khan, Asif H. H.
    Lee, Stella E. E.
    Hopkins, Claire
    Peters, Anju T. T.
    Fokkens, Wytske
    Praestgaard, Amy
    Radwan, Amr
    Nash, Scott
    Jacob-Nara, Juby A. A.
    Deniz, Yamo
    Rowe, Paul J. J.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (03) : 668 - 678
  • [9] DUPILUMAB IMPROVES PATIENT-REPORTED OUTCOMES IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AND COMORBID ASTHMA: SINUS-24/SINUS-52 TRIALS
    Gevaert, P.
    Bachert, C.
    Desrosiers, M.
    Mullol, J.
    Maspero, J.
    Zhang, M.
    Mao, X.
    Kamat, S.
    Khan, A.
    Amin, N.
    Staudinger, H.
    Mannent, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S58 - S59
  • [10] Efficacy of dupilumab in chronic rhinosinusitis with nasal polyps and comorbid asthma by baseline biomarkers of type 2 inflammation: SINUS-24 and SINUS-52 phase 3 trials
    Maspero, J. F.
    Bachert, C.
    Canonica, G. W.
    Swanson, B. N.
    Cho, S. H.
    Harel, S.
    Jagerschmidt, A.
    Zhang, M.
    Mao, X.
    Mannent, L. P.
    Amin, N.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (01): : 173 - 174
12345